It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do ...

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required ...

Stemline Therapeutics Inc’s (NASDAQ:STML): Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovering, acquiring, developing, and commercialization of ...

It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and ...

Investors are always looking for stocks that are poised to beat at earnings season and Stemline Therapeutics, Inc. ( STML) may be one such company. The firm has earnings coming up pretty soon, and ...

Stemline Therapeutics, Inc. (NASDAQ:STML) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Stemline Therapeutics, Inc. has just filed its paperwork ...

Investors certainly have to be happy with Stemline Therapeutics, Inc. (NASDAQ:STML) and its short term performance. After all, the stock has jumped by 40.3% in the past 4 weeks, and it is also above ...